1. Home
  2. BIO vs AXS Comparison

BIO vs AXS Comparison

Compare BIO & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$382.31

Market Cap

8.0B

Sector

Industrials

ML Signal

N/A

Logo Axis Capital Holdings Limited

AXS

Axis Capital Holdings Limited

N/A

Current Price

$100.10

Market Cap

7.3B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
AXS
Founded
1952
2001
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Property-Casualty Insurers
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.3B
IPO Year
1994
2003

Fundamental Metrics

Financial Performance
Metric
BIO
AXS
Price
$382.31
$100.10
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$339.75
$121.29
AVG Volume (30 Days)
242.4K
489.1K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
1.80%
EPS Growth
142.61
N/A
EPS
N/A
3.29
Revenue
$2,583,200,000.00
$6,563,678,000.00
Revenue This Year
$2.74
$2.53
Revenue Next Year
$3.20
$6.95
P/E Ratio
N/A
$30.17
Revenue Growth
0.65
10.17
52 Week Low
$236.73
$88.07
52 Week High
$396.23
$119.99

Technical Indicators

Market Signals
Indicator
BIO
AXS
Relative Strength Index (RSI) 61.40 45.04
Support Level $284.88 $97.57
Resistance Level $396.23 $102.76
Average True Range (ATR) 9.76 1.60
MACD -2.77 0.33
Stochastic Oscillator 58.20 44.32

Price Performance

Historical Comparison
BIO
AXS

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About AXS Axis Capital Holdings Limited

Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States (U.S.), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of Insurance and Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States, and also has its presence in Ireland, Lloyd's of London, and Bermuda.

Share on Social Networks: